Aspirin Products Recalled Due to Improper Storage Conditions at Family Dollar
Multiple aspirin products sold at Family Dollar Stores have been recalled due to storage temperature deviations during distribution from April 30 through June 10, 2022.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves storage temperature deviations without reported illnesses or injuries. Per the severity rubric, voluntary precautionary recalls without reported adverse events are classified as Moderate.
Plain-English summary
Multiple aspirin products sold at Family Dollar Stores are being recalled due to product storage quality concerns. The recalled products include FW Aspirin Chewable Tablets (SKU 913990), GS Enteric Aspirin Tablets (SKU 913724), Bayer Back Body Extra Strength Caplets (SKU 900438), Bayer Low Dose 81 mg Tablets (SKU 916070), Bayer Aspirin 325 mg Tablets (SKU 913996), Bayer Low Dose Tablets (SKU 915641), and Bayer 81 mg Chewable Tablets (SKU 916078).
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. The products were held outside appropriate storage temperature conditions during distribution. These products were distributed to specific Family Dollar Stores from April 30, 2022 through June 10, 2022. The recall is being conducted by the FDA.
The recalled product
- Product
- FW ASPIRIN CHEWABLE TABLET 36CT SKU 913990 GS ENTERIC ASPIRIN TABLET 120 CT SKU 913724 BAYER BACK BODY EX STRGTH CAPLETS 24CT SKU 900438 BAYER LOW DOSE 81 MG TABLET 120 CT SKU 916070 BAYER ASPIRIN 325MG TABLET 24CT SKU 913996 BAYER LOW DOSE TABLET 32CT SKU 915641 BAYER
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- SKUs: 913990
- 913724
- 900438
- 916070
- 913996
- 915641
- 916078
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27